Molecular Mechanism and Targeted Therapy Options of Triple-Negative (ER, PgR, HER-2/neu) Breast Cancer: Review

Tripple negative breast cancer (TNBC) accounts for approximately 15% of breast cancers. It is defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER-2 Over expression. Expression of ER, PR and HER-2 plays an important role in therapeutic assessment of patients with bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandula, Mahesh, Ch, Kalyan Kumar, YS, Ammi Raju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649777/
https://www.ncbi.nlm.nih.gov/pubmed/29147345
http://dx.doi.org/10.4021/wjon681e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649777/
https://www.ncbi.nlm.nih.gov/pubmed/29147345
http://dx.doi.org/10.4021/wjon681e

Ejemplares similares